Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Crossover Experiments01:16

Crossover Experiments

2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.1K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

146
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
146
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.6K
Group Design02:01

Group Design

9.4K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of clinical utility in emulated clinical trials.

European journal of epidemiology·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026
Same author

Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine.

NPJ vaccines·2026
Same author

Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome.

Journal of clinical immunology·2026
Same author

The prevalence and clinical significance of clonal monocytosis.

Blood·2026
Same author

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Vaccine·2026
Same journal

A Bayesian functional concurrent zero-inflated Dirichlet-multinomial regression model with application to infant microbiome.

Biostatistics (Oxford, England)·2026
Same journal

Towards optimal environmental policies: policy learning under arbitrary bipartite network interference.

Biostatistics (Oxford, England)·2026
Same journal

Multilevel functional quantile principal component analysis.

Biostatistics (Oxford, England)·2026
Same journal

Adaptive transfer learning for time-to-event modeling with applications in disease risk assessment.

Biostatistics (Oxford, England)·2026
Same journal

High-dimensional test for one-sided hypotheses.

Biostatistics (Oxford, England)·2026
Same journal

NBSR: a Negative Binomial Softmax Regression model for microRNA-seq data analysis.

Biostatistics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.0K

Cross-direct effects in settings with two mediators.

Erin E Gabriel1, Arvid Sjölander2, Dean Follmann3

  • 1Section of Biostatistics, Department of Public Health, University of Copenhagen, Øster Farimagsgade 5, 1353 Køpenhavn, Denmark.

Biostatistics (Oxford, England)
|September 2, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces new causal effect estimands for scenarios with multiple mediators, expanding beyond natural (NDE) and controlled direct effects (CDE). These methods are applicable to complex biological systems, including immunology and vaccine responses.

Keywords:
Causal pathwaysMultiple mediationSymbolic bounds

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

Related Experiment Videos

Last Updated: Aug 30, 2025

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities
10:26

Problem-Solving Before Instruction PS-I: A Protocol for Assessment and Intervention in Students with Different Abilities

Published on: September 11, 2021

4.0K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

Area of Science:

  • Causal inference
  • Biostatistics
  • Immunology

Background:

  • Traditional causal inference focuses on natural (NDE) and controlled direct effects (CDE).
  • Multiple mediators in biological systems, like immune responses, necessitate advanced analytical approaches.
  • Existing methods may not fully capture complex interactions when multiple mediators are present.

Purpose of the Study:

  • To introduce novel causal effect estimands for situations involving two mediators.
  • To address cross-controlled direct effects and cross-natural direct effects.
  • To provide methods applicable to both sequential and non-sequential mediator scenarios.

Main Methods:

  • Development of five new estimands for cross-CDE and cross-NDE.
  • Formulation of identifying expressions for observational data without residual confounding.
  • Derivation of tight symbolic bounds for randomized settings with potential residual confounding.

Main Results:

  • Introduction of five novel causal estimands for dual-mediator systems.
  • Methods provided for arbitrary mediator and outcome types in observational studies.
  • Bounds established for randomized experiments with binary variables and potential confounding.

Conclusions:

  • The proposed estimands offer a more comprehensive understanding of causal pathways with multiple mediators.
  • These methods have direct applications in fields like immunology, particularly for vaccine response studies.
  • The work extends causal inference techniques to complex biological and observational data settings.